410 related articles for article (PubMed ID: 26203066)
1. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
2. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
Czarnek N; Clark K; Peters KB; Mazurowski MA
J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
[TBL] [Abstract][Full Text] [Related]
3. Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
Lee J; Jain R; Khalil K; Griffith B; Bosca R; Rao G; Rao A
AJNR Am J Neuroradiol; 2016 Jan; 37(1):37-43. PubMed ID: 26471746
[TBL] [Abstract][Full Text] [Related]
4. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.
Peeken JC; Hesse J; Haller B; Kessel KA; Nüsslin F; Combs SE
Strahlenther Onkol; 2018 Jun; 194(6):580-590. PubMed ID: 29442128
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
[TBL] [Abstract][Full Text] [Related]
6. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
Chaddad A; Desrosiers C; Hassan L; Tanougast C
Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
[TBL] [Abstract][Full Text] [Related]
7. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
Paik W; Kim HS; Choi CG; Kim SJ
Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
[TBL] [Abstract][Full Text] [Related]
8. Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
Kotrotsou A; Elakkad A; Sun J; Thomas GA; Yang D; Abrol S; Wei W; Weinberg JS; Bakhtiari AS; Kircher MF; Luedi MM; de Groot JF; Sawaya R; Kumar AJ; Zinn PO; Colen RR
J Neurooncol; 2018 Aug; 139(1):125-133. PubMed ID: 29619649
[TBL] [Abstract][Full Text] [Related]
9. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
10. Computer-extracted MR imaging features are associated with survival in glioblastoma patients.
Mazurowski MA; Zhang J; Peters KB; Hobbs H
J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504
[TBL] [Abstract][Full Text] [Related]
11. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
[TBL] [Abstract][Full Text] [Related]
12. Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.
Palmer JD; Bhamidipati D; Shukla G; Sharma D; Glass J; Kim L; Evans JJ; Judy K; Farrell C; Andrews DW; Wang ZW; Peiper SC; Werner-Wasik M; Shi W
Am J Clin Oncol; 2019 May; 42(5):481-486. PubMed ID: 30973372
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R
Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.
Kang Y; Hong EK; Rhim JH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SW; Choi SH
Korean J Radiol; 2020 Jun; 21(6):707-716. PubMed ID: 32410409
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
16. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tumor shape features for overall survival prognosis in glioblastoma multiforme patients.
Sanghani P; Ti AB; Kam King NK; Ren H
Surg Oncol; 2019 Jun; 29():178-183. PubMed ID: 31196485
[TBL] [Abstract][Full Text] [Related]
18. The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.
Choi YS; Kim DW; Lee SK; Chang JH; Kang SG; Kim EH; Kim SH; Rim TH; Ahn SS
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2235-41. PubMed ID: 26338911
[TBL] [Abstract][Full Text] [Related]
19. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
[TBL] [Abstract][Full Text] [Related]
20. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
